drugset / Trial / NCT02318303
To Study GSP 301 in Patients With Seasonal Allergic Rhinitis
RandomizedParallel-groupDouble-blindTreatment
Summary
Study to evaluate the two different strengths and dose regimen of GSP 301 to be effective in treatment of seasonal allergic rhinitis.
Timeline
- Start
- 2014-12
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mometasone | Other / unclassified | 25 ug | Intranasal |
| Comparator | Mometasone | Other / unclassified | 50 ug | Intranasal |
| Comparator | Olopatadine | Other / unclassified | 665 ug | Intranasal |